19Mar 2023
Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma

Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma

The fight against rare cancers is challenging due to missed or wrong diagnoses, lack of information, diagnostic tools, funding, and too few samples. However, studying well-defined, rare cancers has led to advances in cancer biology. Fibrolamellar hepatocellular carcinoma (FLC) is a rare and lethal liver cancer mainly affecting adolescents and young adults. It is difficult to diagnose, and little is known about its genetic inheritance or somatic mutation. Through a personal journey of a decade of work, answers to these questions and a roadmap of steps and missteps in fighting this rare cancer have been revealed.

  • #oncology

Like

Save

Share